AI Industry Innovations , AI Technologies , Generative AI

Innovating Patient Care by Applying AI to EHR Data

Terry Myerson on How Life Science Companies Use De-Identified Patient Data
Terry Myerson, CEO of Truveta
Terry Myerson, CEO, Truveta

Truveta is a collaborative effort whose members include dozens of the largest healthcare systems in the U.S. It helps life sciences companies apply AI to a trove of electronic health records data to develop new treatments and study their effectiveness, said the organization's CEO, Terry Myerson.

See Also: Healthcare Edition: Trends in Generative AI Tool Adoption and Security Challenges

Truveta, which was launched in the midst of the COVID-19 pandemic, works to create a secure and collaborative environment that facilitates the use of EHR data for AI applications, and it focuses on ethics, security and improving patient outcomes, he said.

"Our healthcare members didn't have the data they needed to figure out how to treat their patients: Who should be intubated for how long? Which of the many drugs that were theorized to be effective against treating COVID should be used?

"And at the same time, the life science organizations were racing ahead with these innovative vaccines and trying to understand to what extent new therapies were effective. There was a lack of data to make these really important decisions that were impacting so many people's lives," he said.

Truveta set up a governance framework for de-identifying the sensitive EHR data of its member organizations, and then put that data to work to help in caring for patients. The company uses its own AI model, the Truveta Language Model, to structure and clean raw health records. This model extracts concepts from clinical notes, mapping ontologies and making data available for analytics or training other AI models, according to Myerson.

Moderna and Pfizer are among the Truveta clients that apply AI tools to this de-identified data to study the safety and effectiveness of their therapies.

"We've seen data come in daily. For folks that are building vaccines for infectious diseases, it is quite meaningful to see the spread of the influenza vaccine versus RSV vaccine versus COVID vaccines on a daily basis across the country," he said.

In this video interview with Information Security Media Group, Myerson also discussed:

  • How Truveta member organizations share their EHR data through a federated model and how a SaaS application, Truveta Embassy, is applied to structure, normalize and de-identify the healthcare data;
  • Considerations made for patient consent and data use;
  • How Truveta data is protected from cyberattacks.

Prior to co-founding Truveta, Myerson worked for 21 years at Microsoft, leading development of Windows, Xbox and Office 365.


About the Author

Marianne Kolbasuk McGee

Marianne Kolbasuk McGee

Executive Editor, HealthcareInfoSecurity, ISMG

McGee is executive editor of Information Security Media Group's HealthcareInfoSecurity.com media site. She has about 30 years of IT journalism experience, with a focus on healthcare information technology issues for more than 15 years. Before joining ISMG in 2012, she was a reporter at InformationWeek magazine and news site and played a lead role in the launch of InformationWeek's healthcare IT media site.




Around the Network

Our website uses cookies. Cookies enable us to provide the best experience possible and help us understand how visitors use our website. By browsing aitoday.io, you agree to our use of cookies.